940908-79-2

940908-79-2 structure

Name: R-7128
Chemical Name: [(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-fluoro-4-methyl-3-(2-methylpropanoyloxy)oxolan-2-yl]methyl 2-methylpropanoate
CAS Number: 940908-79-2
Molecular Formula: C₁₈H₂₆FN₃O₆
Molecular Weight: 399.41400
Catalog: Signaling Pathways Anti-infection HCV
Create Date: 2017-10-27 01:20:35
Modify Date: 2024-01-01 19:21:23
Mericitabine (R-7128) is a nucleoside inhibitor of the HCV NS5B polymerase that acts as an RNA chain terminator and prevents elongation of RNA transcripts during replication.

Name	[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-fluoro-4-methyl-3-(2-methylpropanoyloxy)oxolan-2-yl]methyl 2-methylpropanoate
Synonyms	CS-0596 R-7128 Mericitabine (USAN/INN) RG 7128 Mericitabine

Description	Mericitabine (R-7128) is a nucleoside inhibitor of the HCV NS5B polymerase that acts as an RNA chain terminator and prevents elongation of RNA transcripts during replication.
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> HCV Protease Signaling Pathways >> Anti-infection >> HCV Research Areas >> Infection
Target	HCV NS5B polymerase[1]
In Vitro	Mericitabine (R-7128) is an oral prodrug of PSI-6130, a cytidine analogue. Pre-clinical observations demonstrated that PSI-6130 has an EC90 value of 4.6±2 μM in the HCV replicon assay. Mericitabine shows high specificity for HCV, minimal cytotoxicity and does not affect mitochondrial DNA. PSI-6130 is converted through phosphorylation by cellular kinases to an active 5′-triphosphate metabolite, which inhibits the NS5B RNA polymerase of HCV. Mericitabine demonstrates a relatively good safety profile and significant potency against HCV-1[2]. Mericitabine is a first-in class nucleoside polymerase inhibitor (NPI), which requires intracellular uptake and phosphorylation to two active triphosphates. R-7128 is an oral cytidine nucleoside analog prodrug that exhibits strong antiviral effectiveness against the HCV polymerase across all HCV genotypes[3].
References	[1]. Le Pogam S, et al. Characterization of HCV quasispecies dynamics upon short term dual-therapy with the HCV NS5B nucleoside polymerase inhibitor mericitabine and the NS3/4 protease inhibitor danoprevir. Antimicrob Agents Chemother. 2012 Nov;56(11):5494-5 [2]. Soriano V, et al. Directly acting antivirals against hepatitis C virus. J Antimicrob Chemother. 2011 Aug;66(8):1673-86 [3]. Guedj J, et al. Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128). Hepatology. 2012 Apr;55(4):1030-7.

Molecular Formula	C₁₈H₂₆FN₃O₆
Molecular Weight	399.41400
Exact Mass	399.18100
PSA	123.73000
LogP	1.56050
Storage condition	2-8℃

940908-79-2	1956437-40-3
73981-53-0	158749-75-8
1391515-37-9	122091-54-7
528566-21-4	1391519-06-4
1640848-93-6	352535-00-3
1006477-63-9	1006478-11-0
868153-54-2	873673-96-2
167628-17-3	1159988-16-5
919929-40-1	7271-47-8
113260-45-0	1006440-47-6